Cargando…
Recurrent Pericarditis: a Stubborn Opponent Meets New Treatments in 2022
PURPOSE OF REVIEW: Our goal in writing this review was to provide a comprehensive appraisal of current therapies for idiopathic recurrent pericarditis with a particular focus on the newest therapeutic agents. We sought to understand the role of the inflammasome in the pathophysiology of pericarditis...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130990/ https://www.ncbi.nlm.nih.gov/pubmed/35612721 http://dx.doi.org/10.1007/s11886-022-01719-z |